✦ LIBER ✦

(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl] -3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Scribed by Tesfaye Biftu; et al. et al.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimization of 1,4-Diazepan-2-one-Conta

✍ Gui-Bai Liang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

ChemInform Abstract: (3R,4S)-4-(2,4,5-Tr

✍ Stephen W. Wright; et al. et al. 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 18 KB 👁 1 views

Synthesis of 4-Amino-6-R-4,5-dihydro-3-p

✍ I. M. Bazavova; V. N. Britsun; A. N. Esipenko; M. O. Lozinskii 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 89 KB 👁 1 views

Acetyl Derivatives of 3-(5-R-Amino- [1,3

✍ I. A. Zhuravel'; S. N. Kovalenko; V. P. Chernykh; P. E. Shinkarenko 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 12 KB 👁 1 views

Synthesis of 4-Trifluoromethyl-3,4-dihyd

✍ A. V. Biitseva; O. V. Gordienko; M. Yu. Kornilov; V. A. Sukach; M. V. Vovk; O. V 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 25 KB

ChemInform Abstract: Discovery of a Fact

✍ Wolfgang Haap; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

## Abstract Compound (I) is found to be a potent, selective and orally bioavailable fXa inhibitor based on a pyrrolidine scaffold.